4th Quarter - Report

ARENTFOX SCHIFF LLP for ORGANOGENESIS INC.

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare reimbursement policy for chronic wound healing products

LobbyistCovered position, as disclosed
SONJA NESBIT New Deputy Staff Director, Subcommittee on Human Resources, Committee on Ways and Means; Professional Staff, Subcommittee on Human Resources, Committee on Ways and Means
DAN RENBERG —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Medical device excise tax generally

LobbyistCovered position, as disclosed
SONJA NESBIT New Deputy Staff Director, Subcommittee on Human Resources, Committee on Ways and Means; Professional Staff, Subcommittee on Human Resources, Committee on Ways and Means
DAN RENBERG —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Food and Drug Administration policy on chronic wound healing products Food and Drug Administration user fee policy H.R. 2430 and S. 934 (FDA Reauthorization Act of 2017), all provisions Indian Health Service policy on chronic wound healing products Federal research funding for wound healing products

LobbyistCovered position, as disclosed
SONJA NESBIT New Deputy Staff Director, Subcommittee on Human Resources, Committee on Ways and Means; Professional Staff, Subcommittee on Human Resources, Committee on Ways and Means
JAMES RAVITZ —
DAN RENBERG —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 934 (115th), H.R. 2430 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.